Speaker illustration

Doctor Argyrios Ntalianis

Alexandra University Hospital, Athens (Greece)

Member of:

Heart Failure Association

Biomarkers and imaging modalities for the diagnosis of cardiotoxicity after chemotherapy; data from the greek multicenter cardio-oncology registry

Event: Heart Failure 2019

Topic: Cardio-Oncology

Session: Cardiovascular Disease in Special Populations

Thumbnail

Small tolerated enalapril doses before ARNI administration predicts adverse events during ARNI up-titration

Event: Heart Failure 2019

Topic: Pharmacotherapy

Session: Chronic Heart Failure – Treatment

Thumbnail

Hypertrophic cardiomyopathy or light chain cardiac amyloidosis?

Event: Heart Failure 2018

Topic: Hypertrophic Cardiomyopathy

Session: Clinical Case Corner 6 - Such a big, big heart: cases of (pseudo)hypertrophy

Thumbnail

Safety and efficacy of valsartan-sacubitril in a cohort of patients with symptomatic heart failure receiving small doses of ACE

Event: Heart Failure 2018

Topic: Treatment

Session: Chronic Heart Failure – Treatment

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb